Inventor · disambiguated record
Jeffrey J. Letourneau
Also filed as: LETOURNEAU JEFFREY · LETOURNEAU JEFFREY J · LETOURNEAU JEFFREY JOHN
17 granted patents·4 pending applications·83 citations·filing 2000–2022
92Inventor score
Files withLIGAND PHARM INC5VENENUM BIODESIGN LLC5PHARMACOPEIA INC4ORGANON NV3PHARMACOPEIA DRUG DISCOVERY2
Top patents by PatentIndex Score
21 records- 0187US11306098B2Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitorsVENENUM BIODESIGN LLC·Filed 2020·Granted Apr 19, 2022·3 cites·13 claims
- 0287US10030034B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2016·Granted Jul 24, 2018·5 cites·12 claims
- 0387US7479495B2N-heterocyclic inhibitors of TNF-α expressionPHARMACOPEIA INC·Filed 2005·Granted Jan 20, 2009·11 cites·32 claims
- 0486US6906067B2N-heterocyclic inhibitors of TNF-α expressionPHARMACEOPEIA INC·Filed 2001·Granted Jun 14, 2005·35 cites·20 claims
- 0585US9266874B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2013·Granted Feb 23, 2016·2 cites·9 claims
- 0684US10604533B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2018·Granted Mar 31, 2020·1 cites·15 claims
- 0783US11186593B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2020·Granted Nov 30, 2021·1 cites·19 claims
- 0883US7807686B22-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonistsORGANON NV·Filed 2006·Granted Oct 5, 2010·11 cites·15 claims
- 0976US11773110B2Heterocycle amines and uses thereofLIGAND PHARM INC·Filed 2021·Granted Oct 3, 2023·0 cites·11 claims
- 1076US6943161B2Pyrimidine and triazine kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted Sep 13, 2005·7 cites·30 claims
- 1174US11583538B2Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitorsVENENUM BIODESIGN LLC·Filed 2020·Granted Feb 21, 2023·1 cites·22 claims
- 1274US8350043B2Azinone and diazinone V3 inhibitors for depression and stress disordersPHARMACOPEIA INC·Filed 2006·Granted Jan 8, 2013·2 cites·21 claims
- 1365US7365209B2Nitrogen heterocycle biaryls for osteoporosis and other diseasesPHARMACOPEIA INC·Filed 2004·Granted Apr 29, 2008·4 cites·25 claims
- 1461US2022213111A1Substituted heterocycles as cyclic trex1 inhibitorsVENENUM BIODESIGN LLC·Filed 2022·Application pending·0 cites
- 1554US2005277642A1Pyrimidine kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2005·Application pending·0 cites
- 1646US7820649B2Quinazolinone and isoquinolinone acetamide derivativesORGANON NV·Filed 2007·Granted Oct 26, 2010·0 cites·11 claims
- 1745US7906504B22-(1-oxo-1H-isoquinolin-2-yl)acetamide derivativesORGANON NV·Filed 2007·Granted Mar 15, 2011·0 cites·11 claims
- 1842US2008051423A1Nitrogen heterocycle biaryls for osteoporosis and other diseasesPHARMACOPEIA INC·Filed 2007·Application pending·0 cites
- 1941US11236055B2Non-systemic TGR5 agonistsVENENUM BIODESIGN LLC·Filed 2017·Granted Feb 1, 2022·0 cites·23 claims
- 2039US10669242B2Clostridium difficile toxin inhibitorsVENENUM BIODESIGN LLC·Filed 2017·Granted Jun 2, 2020·0 cites·27 claims
- 2138US2002065270A1N-heterocyclic inhibitors of TNF-alpha expressionFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey J. Letourneau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →